Rifampin-resistance-associated mutations in the rifampin-resistance-determining region of the rpoB gene of Mycobacterium tuberculosis clinical isolates in Shanghai, PR China
Introduction. Resistance to rifampin (RIF) in Mycobacterium tuberculosis infection is associated with mutations in the rpoB gene coding for the β-subunit of RNA polymerase. The contribution of various rpoB mutations to the development and level of RIF resistance remains elusive.
Hypothesis/Gap Statement. Various rpoB mutations may be associated with differential levels of RIF resistance.
Aim. This study aimed to investigate the relationship between specific rpoB mutations and the MICs of RIF and rifabutin (RFB) against M. tuberculosis.
Methodology. Of the 195 clinical isolates, 105 and 90 isolates were randomly selected from isolates resistant to RIF and sensitive to RIF, respectively. The MICs of 12 agents for M. tuberculosis isolates were determined using commercial Sensititre M. tuberculosis MIC plates and the broth microdilution method. Strains were screened for rpoB mutations by DNA extraction, rpoB gene amplification and DNA sequence analysis.
Results. One hundred isolates (95.24 %) were found to have mutations in the RIF-resistance-determining region (RRDR) of the rpoB gene. Three rpoB mutations were identified in 90 RIF-susceptible isolates. Out of 105 isolates, 86 (81.90 %) were cross-resistant to both RIF and RFB. The most frequent mutation occurred at codons 450 and 445. We also found a novel nine-nucleotide (ATCATGCAT) deletion (between positions 1543 and 1551) in the rpoB gene in two strains (1.90 %) with resistance to RIF, but susceptibility to RFB. In addition, the mutation frequency at codon 450 was significantly higher in RIF-resistant/RFB-resistant (RIFR/RFBR) strains than in RIFR/RFBS strains (75.58 % versus 21.05 %, P<0.01), whereas the mutation frequency at codon 435 was significantly lower in RIFR/RFBR strains than in RIFR/RFBS strains (1.16 % versus 26.32 %, P<0.01).
Conclusion. Our data support previous findings, which reported that various rpoB mutations are associated with differential levels of RIF resistance. The specific mutations in the rpoB gene in RIFR/RFBR isolates differed from those in the RIFR/RFBS isolates. A novel deletion mutation in the RRDR might be associated with resistance to RIF, but not to RFB. Further clinical studies are required to investigate the efficacy of RFB in the treatment of infections caused by M. tuberculosis strains harbouring these mutations.
SteingartKR,
JotbladS,
RobskyK,
DeckD,
HopewellPC et al. Higher-dose rifampin for the treatment of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis2011; 15:305–316[PubMed]
MenziesD,
BenedettiA,
PaydarA,
MartinI,
RoyceS et al. Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis. PLoS Med2009; 6:e1000146 [View Article][PubMed]
GillespieSH.
Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective. Antimicrob Agents Chemother2002; 46:267–274 [View Article][PubMed]
SomoskoviA,
ParsonsLM,
SalfingerM.
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
. Respir Res2001; 2:164–168 [View Article][PubMed]
BahrmandAR,
TitovLP,
TasbitiAH,
YariS,
GravissEA.
High-level rifampin resistance correlates with multiple mutations in the rpoB gene of pulmonary tuberculosis isolates from the Afghanistan border of Iran. J Clin Microbiol2009; 47:2744–2750 [View Article][PubMed]
RigoutsL,
GumusbogaM,
de RijkWB,
NduwamahoroE,
UwizeyeC et al. Rifampin resistance missed in automated liquid culture system for Mycobacterium tuberculosis isolates with specific rpoB mutations. J Clin Microbiol2013; 51:2641–2645 [View Article][PubMed]
Van DeunA,
AungKJM,
BolaV,
LebekeR,
HossainMA et al. Rifampin drug resistance tests for tuberculosis: challenging the gold standard. J Clin Microbiol2013; 51:2633–2640 [View Article][PubMed]
MarsiliL,
PasqualucciCR,
VigevaniA,
GioiaB,
SchioppacassiG et al. New rifamycins modified at positions 3 and 4. Synthesis, structure and biological evaluation. J Antibiot1981; 34:1033–1038 [View Article][PubMed]
UzunM,
ErturanZ,
AnğO.
Investigation of cross-resistance between rifampin and rifabutin in Mycobacterium tuberculosis complex strains. Int J Tuberc Lung Dis2002; 6:164–165[PubMed]
Clinical and Laboratory Standards InstitutePerformance Standards for Susceptibility Testing of Mycobacteria, Nocardia spp., and Other Aerobic Actinomycetes; approved astandard M62, 1st ed. CLSI; 2018
JamiesonFB,
GuthrieJL,
NeemuchwalaA,
LastovetskaO,
MelanoRG et al. Profiling of rpoB mutations and MICs for rifampin and rifabutin in Mycobacterium tuberculosis
. J Clin Microbiol2014; 52:2157–2162 [View Article][PubMed]
AbbadiSH,
SameaaGA,
MorlockG,
CookseyRC.
Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis
. Int J Infect Dis2009; 13:673–678 [View Article][PubMed]
HillemannD,
WeizeneggerM,
KubicaT,
RichterE,
NiemannS.
Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol2005; 43:3699–3703 [View Article][PubMed]
IslamMM,
HameedHMA,
MugweruJ,
ChhotarayC,
WangC et al. Drug resistance mechanisms and novel drug targets for tuberculosis therapy. J Genet Genomics2017; 44:21–37 [View Article][PubMed]
MoghazehSL,
PanX,
ArainT,
StoverCK,
MusserJM et al. Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations. Antimicrob Agents Chemother1996; 40:2655–2657 [View Article][PubMed]
TanY,
HuZ,
ZhaoY,
CaiX,
LuoC et al. The beginning of the rpoB gene in addition to the rifampin resistance determination region might be needed for identifying rifampin/rifabutin cross-resistance in multidrug-resistant Mycobacterium tuberculosis isolates from southern China. J Clin Microbiol2012; 50:81–85 [View Article][PubMed]
ChenJ,
PengP,
DuY,
RenY,
ChenL et al. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing. BMC Infect Dis2017; 17:300 [View Article][PubMed]
ZaczekA,
BrzostekA,
Augustynowicz-KopecE,
ZwolskaZ,
DziadekJ.
Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin. BMC Microbiol2009; 9:10 [View Article][PubMed]
MakhadoNA,
MatabaneE,
FaccinM,
PinçonC,
JouetA et al. Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study. Lancet Infect Dis2018; 18:1350–1359 [View Article][PubMed]
Sanchez-PadillaE,
MerkerM,
BeckertP,
JochimsF,
DlaminiT et al. Detection of drug-resistant tuberculosis by Xpert MTB/RIF in Swaziland. N Engl J Med2015; 372:1181–1182 [View Article][PubMed]
DonnabellaV,
MartiniukF,
KinneyD,
BacerdoM,
BonkS et al. Isolation of the gene for the beta subunit of RNA polymerase from rifampicin-resistant Mycobacterium tuberculosis and identification of new mutations. Am J Respir Cell Mol Biol1994; 11:639–643 [View Article][PubMed]
HuangH,
JinQ,
MaY,
ChenX,
ZhuangY.
Characterization of rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis isolated in China. Tuberculosis2002; 82:79–83 [View Article][PubMed]
WilliamsDL,
SpringL,
CollinsL,
MillerLP,
HeifetsLB et al. Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis
. Antimicrob Agents Chemother1998; 42:1853–1857 [View Article][PubMed]
KapurV,
LiLL,
IordanescuS,
HamrickMR,
WangerA et al. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol1994; 32:1095–1098 [View Article][PubMed]
BodmerT,
ZürcherG,
ImbodenP,
TelentiA.
Mutation position and type of substitution in the beta-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis
. J Antimicrob Chemother1995; 35:345–348 [View Article][PubMed]
HerreraL,
JiménezS,
ValverdeA,
García-ArandaMA,
Sáez-NietoJA.
Molecular analysis of rifampicin-resistant Mycobacterium tuberculosis isolated in Spain (1996-2001). description of new mutations in the rpoB gene and review of the literature. Int J Antimicrob Agents2003; 21:403–408 [View Article][PubMed]
HiranoK,
AbeC,
TakahashiM.
Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J Clin Microbiol1999; 37:2663–2666 [View Article][PubMed]
Rifampin-resistance-associated mutations in the rifampin-resistance-determining region of the rpoB gene of Mycobacterium tuberculosis clinical isolates in Shanghai, PR China